Criteria Patient–centered measures Improvement in dyspnea No chest pain that would raise concern for acute coronary syndrome (ACS) Ability to ambulate without dyspnea above the baseline Free of symptoms of…
Maintain current immunizations, especially influenza and Streptococcus pneumoniae Develop a system for taking all medications as prescribed Monitor for changes in weight, increase or decrease Monitor for changes in signs/symptoms…
Profile Common precipitants Signs and symptoms Hemodynamics on presentation Profoundly hypertensive Abrupt rise in BP Rapid onset of dyspnea (“flash pulmonary edema”); systemic edema may be absent; diaphoresis with adequate…
(1) The Society of Cardiovascular Patient Care, An Institute of the American College of Cardiology, Dublin, OH, USA (2) Department of Emergency Medicine, Wayne State University School of Medicine, Detroit,…
Fig. 6.1 Percentage of population with the diagnosis of heart failure according to age group (From the Heart Disease and Stroke Statistics – 2016 Update) With the aging of 78…
Edema (APE) Cause Incidence (%) Worsening heart failure 26 Coronary insufficiency 21 Subendocardial infarction 16 Transmural infarction 10 Acute dysrhythmia 9 Medication noncompliance 7 Dietary indiscretion 3 Valvular insufficiency 3…
Fig. 7.1 Cardiac dysfunction in heart failure can be exacerbated by overactivation of initially compensatory neurohormonal systems There is less information regarding the role of maladaptive neurohormonal mechanisms in ADHF,…
Metric number and name NQF # Data collection method Group overseeing the metric ACO-8; risk-standardized all condition readmission 1789 (adapted) Claims data CMS ACO-10; ambulatory sensitive conditions admission: heart failure…
© Springer International Publishing Switzerland 2017W. Frank Peacock (ed.)Short Stay Management of Acute Heart FailureContemporary Cardiology10.1007/978-3-319-44006-4_5 5. Interaction of Performance Measurements, Staffing, and Facility Requirements for the Heart Failure Observation Unit Valorie Sweigart1 and Karen Krechmery1…
Fig. 10.1 A generation 2 WATCHMAN device. ©2014 Boston Scientific Corporation or its affiliates. All rights reserved. Used with permission of Boston Scientific Corporation WATCHMAN Clinical Trials and Evidence Base…
